ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $98,000 | +180.0% | 1,652 | +223.9% | 0.00% | +200.0% |
| Q1 2021 | $35,000 | -42.6% | 510 | -36.1% | 0.00% | -66.7% |
| Q4 2020 | $61,000 | +1120.0% | 798 | +582.1% | 0.00% | +50.0% |
| Q1 2020 | $5,000 | -64.3% | 117 | -63.1% | 0.00% | -33.3% |
| Q4 2019 | $14,000 | -77.8% | 317 | -76.9% | 0.00% | -83.3% |
| Q3 2019 | $63,000 | -58.0% | 1,375 | -57.8% | 0.02% | -64.7% |
| Q3 2018 | $150,000 | – | 3,257 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |